How to Get Ozempic Prescribed: Steps and Requirements

Getting an Ozempic prescription starts with a medical evaluation, typically through your primary care doctor or an endocrinologist, who will determine whether you meet the clinical criteria for the drug and then navigate insurance requirements on your behalf. The process is more involved than simply asking for the medication, because Ozempic carries a specific FDA-approved indication for type 2 diabetes, and using it for weight management alone is technically off-label. Understanding what doctors look for, what insurers require, and what happens once you actually start the medication will save you time, frustration, and potentially a lot of money.

What Ozempic Is Actually Approved For

Ozempic (semaglutide injection) is FDA-approved for improving blood sugar control in adults with type 2 diabetes. It is not approved for weight loss on its own. A higher-dose version of the same drug, branded as Wegovy, does carry FDA approval for chronic weight management. This distinction matters because many clinicians prescribe Ozempic off-label for weight loss, especially since many insurance plans will not cover semaglutide solely for weight management, making the diabetes-labeled version a workaround of sorts.¹ If you are seeking Ozempic specifically for weight loss and do not have a diabetes diagnosis, your path to a prescription is more complicated but not impossible. Your doctor will need to evaluate whether your clinical profile supports the off-label use and whether your insurer will cover it under those circumstances.

Who Qualifies Clinically

Doctors assess eligibility based on your diagnosis and a handful of measurable criteria. For the diabetes indication, you generally need a confirmed type 2 diabetes diagnosis, which could be established by self-report, an HbA1c level at or above 7%, or existing use of diabetes medications. For weight management, the standard threshold is a body mass index of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related condition such as high blood pressure, high cholesterol, or a history of heart attack or stroke.² A third, more recent indication involves cardiovascular disease prevention for people aged 45 and older who have a BMI of at least 27 and a history of heart attack or stroke.

In practice, the bar your doctor applies will depend on the indication they’re writing the prescription under and which criteria your insurer recognizes. A person with a BMI of 29 and high blood pressure may qualify under weight management criteria but will likely face more pushback from insurance than someone with a clear diabetes diagnosis. If you’re unsure where you fall, bringing recent lab work and a list of your current diagnoses to the appointment helps move things along.

What Happens at the Doctor’s Visit

Before writing a prescription, your doctor will typically run baseline bloodwork and review your medical history. A study examining pre-treatment assessments of semaglutide users found that standard labs included HbA1c, serum creatinine, thyroid function markers (TSH, T3, T4), triglycerides, HDL, LDL, total cholesterol, and total bilirubin.³ These tests serve two purposes: they confirm the diagnosis that justifies the prescription (such as elevated HbA1c for diabetes), and they establish a baseline so your doctor can track how your body responds over time.

That same study raised a concern worth knowing about. None of the patients in the cohort had their pancreatic lipase, amylase, or calcitonin levels measured before starting semaglutide.³ Pancreatic enzyme levels can flag existing pancreatic issues, and calcitonin is relevant because GLP-1 receptor agonists like semaglutide carry a boxed warning about thyroid C-cell tumors observed in animal studies. If your doctor does not mention these tests, it is reasonable to ask about them, particularly if you have a personal or family history of pancreatitis or thyroid cancer.

Beyond the labs, expect your doctor to ask about your eating habits, physical activity, mental health history, and any medications you’re currently taking. This is not a checkbox exercise. Several of these factors influence whether Ozempic is the right fit or whether a different medication might serve you better.

The Insurance Hurdle

For many people, the hardest part of getting Ozempic is not the medical evaluation but the insurance approval. Even among plans that cover semaglutide, prior authorization requirements have surged. Among Medicare Part D plans that covered these therapies, prior authorization requirements were below 25% until mid-2023 but then jumped sharply, reaching roughly 83% for injectable semaglutide by the third quarter of 2024.⁴ Private insurers have followed a similar trajectory, though the specifics vary by plan.

Prior authorization means your doctor’s office must submit documentation proving you meet the insurer’s criteria before the pharmacy will fill the prescription. This typically involves lab results, your BMI, a list of comorbidities, and sometimes evidence that you tried other treatments first (like metformin for diabetes, or a structured diet program for weight management). The process can take days to weeks, and denials are common on the first attempt. If you’re denied, your doctor can file an appeal, and many patients succeed on appeal when additional documentation is provided.

If your insurance does not cover Ozempic at all, or if you are uninsured, the out-of-pocket cost for the brand-name drug is substantial, often exceeding $900 per month at retail price. Novo Nordisk, the manufacturer, offers savings programs for commercially insured patients, and some patients turn to patient assistance programs. Your doctor’s office or a specialty pharmacy can usually point you toward current options, though these programs change frequently.

How Dosing Works Once You Start

Ozempic is injected once a week, and the standard protocol involves a slow dose escalation to minimize side effects, particularly nausea. You start at a low dose and increase every four weeks until reaching a maintenance level. In practice, though, the textbook schedule and what actually happens in the real world differ quite a bit. A large Danish cohort study found that only about 10% of users followed the recommended four-week dose escalation timeline. Just 13% reached the maximum dose of 2.4 mg by their fifth prescription, and between a third and half of users stayed on a 1.0 mg dose from their fourth prescription onward rather than continuing to increase.⁵

This matters for your expectations. Many people tolerate lower doses well and see meaningful results without ever reaching the maximum dose. Others find that side effects at higher doses, especially gastrointestinal symptoms like nausea, vomiting, and diarrhea, are hard to manage. Your doctor should be adjusting the dose based on your response and tolerance, not simply following a rigid schedule. About 6% of users in the Danish study stopped after a single prescription, which underscores how important it is to keep in touch with your prescriber during the early weeks.⁵

Contraindications and Who Should Be Cautious

Not everyone can safely take Ozempic, and there are specific conditions that should make both you and your doctor pause. The drug carries a boxed warning regarding thyroid C-cell tumors, so it is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. Beyond that absolute contraindication, several patient-specific vulnerabilities warrant extra caution:

Gallbladder disease: GLP-1 drugs are associated with gallbladder problems, and people with a history of gallstones or cholecystitis need closer monitoring.
Kidney concerns: Dehydration from gastrointestinal side effects like vomiting and diarrhea can worsen kidney function, particularly in people with pre-existing kidney disease.
Diabetic retinopathy: Rapid improvement in blood sugar control can temporarily worsen diabetic eye disease, so people with existing retinopathy need ophthalmologic follow-up.
Frailty or muscle loss: The weight lost on semaglutide includes some lean muscle mass, which can be a serious problem for older adults or anyone already at risk of sarcopenia.

A review of adverse events linked to incretin-based therapies concluded that prescribers should align drug selection, dose escalation speed, and monitoring intensity with these patient-specific risks.⁶ In other words, a healthy 40-year-old with a BMI of 32 and no other health issues will have a very different risk profile than a 70-year-old with diabetes and a history of gallstones. If your prescriber isn’t discussing these factors with you, bring them up.

Pregnancy Planning and Reproductive Safety

If you are someone who could become pregnant, timing matters. Semaglutide has a long half-life of about seven days, meaning it stays in your system well after you stop injecting. Current guidance suggests discontinuing semaglutide at least 35 days before attempting conception to allow the drug to fully clear from your body.⁷ Some experts suggest a four-week washout period as a reasonable minimum.⁸

This is particularly important because GLP-1 drugs can increase fertility by restoring ovulation in people whose cycles were disrupted by obesity or insulin resistance. There have been widely reported anecdotal cases of unplanned pregnancies in people taking semaglutide who did not realize their fertility had changed. If you are using hormonal birth control, be aware that severe gastrointestinal side effects like vomiting can reduce the effectiveness of oral contraceptives. Discuss backup contraception methods with your doctor when starting the medication, and have a clear plan for when to stop if pregnancy is on the horizon.

Why Compounded Versions Are Risky

During semaglutide shortages, compounding pharmacies began producing their own versions of the drug, typically using semaglutide salt forms rather than the branded product. These compounded versions are not FDA-approved and are not subject to the same manufacturing standards. A pharmacovigilance study analyzing FDA adverse event reports found that compounded GLP-1 receptor agonists had meaningfully higher rates of adverse events compared to the manufactured versions. Compounded products showed higher reporting odds for abdominal pain, diarrhea, nausea, and, more alarmingly, for suicidality and gallbladder inflammation.⁹

The safety signals went beyond side effects. Compounded products had dramatically higher odds of preparation errors, prescribing errors, contamination issues, and manufacturing problems. The odds of hospitalization were more than twice as high for compounded products compared to branded ones.⁹ None of this means every compounded semaglutide product will cause harm, but the risk profile is clearly different. If you are considering a compounded version because of cost or supply issues, discuss the tradeoffs with your doctor. When the branded product is available and accessible to you, it is the safer choice.

The Role of Lifestyle Changes

Your doctor will almost certainly discuss diet and exercise alongside the prescription, and this is not a formality. Semaglutide works in part by reducing appetite and slowing gastric emptying, but outcomes improve when the medication is paired with deliberate changes to eating patterns and physical activity.¹⁰ Clinical trials of semaglutide for weight management included structured lifestyle intervention programs, so the results you see quoted in headlines reflect what happens when the drug and behavior changes work together.

In practical terms, this means paying attention to protein intake (to protect muscle mass during weight loss), incorporating resistance training when possible, and adjusting portion sizes as your appetite naturally decreases. Many people find that semaglutide changes their relationship with food in ways that make healthier choices feel easier, but the drug does not override poor habits entirely. If you stop the medication without having built sustainable eating and exercise patterns, regain is common. Think of the prescription as a window of opportunity rather than a permanent solution.

Telehealth and Direct-to-Consumer Prescribing

A growing number of telehealth platforms now offer semaglutide prescriptions through online consultations. These services typically involve a brief questionnaire, a video or asynchronous chat with a clinician, and, if you qualify, a prescription shipped to your door. The appeal is obvious: no waiting weeks for an in-person appointment, no navigating a primary care office that may be unfamiliar with weight management protocols. Some of these platforms work with compounding pharmacies, and as covered above, that adds a layer of risk you should factor in.

The quality of telehealth evaluations varies enormously. A thorough provider will still want to see lab results, review your medical history in detail, and discuss contraindications before prescribing. A less thorough one may rely on self-reported information and skip baseline testing. If a telehealth service offers you a prescription without asking about your thyroid history, kidney function, or current medications, that is a red flag. The convenience of the platform does not change the medical requirements for safe prescribing. Look for services that require recent labs and have a clear follow-up plan, not just a single prescribing encounter.

What to Do if Your Doctor Says No

Doctors decline Ozempic requests for a variety of reasons. Sometimes the clinical criteria simply are not met. Sometimes the doctor has concerns about a specific contraindication or feels another medication is more appropriate for your situation. And sometimes the refusal reflects the broader tension around prescribing a diabetes drug for weight loss, particularly when supply shortages have affected patients with diabetes who depend on it.

If you feel the refusal was not well-explained, you have options. Ask your doctor to walk through the specific clinical reasoning. If the issue is insurance coverage rather than medical eligibility, ask about alternatives: a different GLP-1 drug that your plan covers, a referral to an obesity medicine specialist, or a formal weight management program that could strengthen a future prior authorization request. Obesity medicine specialists are often more experienced with the prescribing and insurance landscape for these drugs and may be more willing to pursue authorization appeals. Getting a second opinion is always within your rights, and the landscape is shifting quickly enough that what one clinician considers outside their comfort zone, another may handle routinely.